title: Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
abstract: In the liver, transforming growth factor (TGF) -beta(1)is primarily responsible for activation of fat-storing cells, which are the main source of extracellular matrix proteins. Their deposition play a key role in the development of liver cirrhosis. The aim of this study was to evaluate plasma TGF-beta(1)in patients with different stages of liver cirrhosis and its possible use as an indicator of liver function impairment. TGF-beta(1)was measured in the plasma of 40 patients with liver cirrhosis. To estimate possible effect of liver insufficiency on plasma TGF-beta(1), patients were divided into three groups: A, B and C, univocal with Child-Pugh classes. Normal values were collected from 13 healthy volunteers. Liver cirrhosis resulted in a significant increase of plasma concentration of TGF-beta(1)(39.3+/-3.8 ng/ml), which doubled normal values (18.3+/-1.6 ng/ml). The highest concentrations were observed in alcoholic patients (44.4+/-4.7 ng/ml). TGF-beta(1)level increased depending on the degree of liver insufficiency, demonstrated by a significant positive correlation with Child-Pugh score (r=0.591). Values in group A were similar to normal, but were significantly elevated in groups B and C. These findings suggest possible use of plasma TGF-beta(1)measurement as an indicator of liver function impairment and possible marker of hepatic fibrosis progression in cirrhotic patients.
authors.affiliation: Department of Infectious Diseases, Medical Academy of Bialystok, Bialystok, Poland. flisiakr@priv.onet.pl
authors.forename: R
authors.initials: R
authors.lastname: Flisiak
authors.forename: B
authors.initials: B
authors.lastname: Pytel-Krolczuk
authors.forename: D
authors.initials: D
authors.lastname: Prokopowicz
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D005260:Female; D006501:Hepatic Encephalopathy / Q000097:blood / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000145:classification / Q000503:physiopathology*; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood / Q000503:physiopathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D012016:Reference Values; D016212:Transforming Growth Factor beta / Q000097:blood*
chemical_list: D015415:Biomarkers; D016212:Transforming Growth Factor beta; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin